Another meaning for NK
https://www.bloomberg.com/research/stocks/private/snapshot.asp?privcapId=262241549
Company Overview
NantKwest, Inc., a clinical-stage immunotherapy biotechnology company, develops immunotherapeutic treatments for cancer, infectious diseases, and inflammatory diseases in the United States. The company develops activated natural killer cell, a natural killer cell-line and genetically modified derivative capable of killing cancer and virally infected cells; and NANT cancer vaccine, a personalized therapy that utilizes its off-the-shelf natural killer cells. It is also developing high-affinity natural killer product candidates primarily for the treatment of various cancers; and target activated natural killer product candidates to treat hematological malignancies and solid tumors. NantKwest,
Nantkwest Inc
NK (NASDAQ)
3.29USD0.13 (3.80%)
Closed: Jul. 20, 4:37 p.m. EDT - Disclaimer
After-hours: 3.290.00 (0.00%)